U.S. Markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.3560%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.3207%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.1145%)
     
  • BTC-USD

    13,005.29
    -306.83 (-2.30%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Andreas Halvorsen Jumps on PMV Pharmaceuticals

GuruFocus.com
·2 mins read

- By Graham Griffin

Andreas Halvorsen (Trades, Portfolio) revealed he established a new position in PMV Pharmaceuticals Inc. (NASDAQ:PMVP) on Sept. 25, according to GuruFocus' Real-Time Picks.


Halvorsen, a "Tiger Cub," learned under Julian Robertson (Trades, Portfolio) of Tiger Management prior to founding Viking Global Investors in 1999. The firm considers fundamentals and management to be some of the most important aspects when identifying investment opportunities, but it also considers cyclical and industry trends.

The guru purchased 2.64 million shares during the first day of public trading for the company. The purchase had a 0.43% impact on the equity portfolio. The stock opened at $35 and spiked as high as $40.97 during its first day of trading.

Andreas Halvorsen Jumps on PMV Pharmaceuticals
Andreas Halvorsen Jumps on PMV Pharmaceuticals

PMV Pharmaceuticals was founded in 2013 and is developing targeted therapies for cancer. Currently in development is a small-molecule therapy that targets p53 mutations. P53 is a tumor-suppressive protein that has the ability to eliminate cancer cells in the body.

As of Oct. 6, shares were trading at $32.45 with a market cap of $1.45 billion.

Andreas Halvorsen Jumps on PMV Pharmaceuticals
Andreas Halvorsen Jumps on PMV Pharmaceuticals

Portfolio overview

Halvorsen has become increasingly invested in health care companies with other recent purchases including Athira Pharam Inc. (NASDAQ:ATHA), GoHealth Inc. (NASDAQ:GOCO) and Inhibrx Inc. (NASDAQ:INBX) earlier this year. By weight, his portfolio is most invested in the health care (32.64%), technology (19.28%) and consumer cyclical (18.94%) sectors.

Andreas Halvorsen Jumps on PMV Pharmaceuticals
Andreas Halvorsen Jumps on PMV Pharmaceuticals

Overall, the portfolio contains 71 stocks, with 23 new holdings at the end of the second quarter. His top holdings are Amazon Inc. (NASDAQ:AMZN), Adaptive Biotechnologies Corp. (NASDAQ:ADPT), Comcast Corp. (NASDAQ:CMCSA), Centene Corp. (NYSE:CNC) and American Express Co. (NYSE:AXP).

Disclaimer: Author owns no stocks mentioned.

Read more here:

  • Chase Coleman Burns Off Sunrun Holding

  • Tesla's Chinese Rivals Boast Record Deliveries

  • Nikola's Struggling Share Prices Delay GM Partnership



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.